ID   ECHM_HUMAN              Reviewed;         290 AA.
AC   P30084; O00739; Q5VWY1; Q96H54;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   26-APR-2005, sequence version 4.
DT   10-MAY-2017, entry version 185.
DE   RecName: Full=Enoyl-CoA hydratase, mitochondrial;
DE            EC=4.2.1.17 {ECO:0000269|PubMed:26251176};
DE   AltName: Full=Enoyl-CoA hydratase 1;
DE   AltName: Full=Short-chain enoyl-CoA hydratase;
DE            Short=SCEH;
DE   Flags: Precursor;
GN   Name=ECHS1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANTS ALA-11 AND ILE-75.
RC   TISSUE=Liver;
RX   PubMed=8012501;
RA   Kanazawa M., Ohtake A., Abe H., Yamamoto S., Satoh Y., Takayanagi M.,
RA   Niimi H., Mori M., Hashimoto T.;
RT   "Molecular cloning and sequence analysis of the cDNA for human
RT   mitochondrial short-chain enoyl-CoA hydratase.";
RL   Enzyme Protein 47:9-13(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ALA-11 AND ILE-75.
RX   PubMed=9073515; DOI=10.1006/geno.1996.4597;
RA   Janssen U., Davis E.M., le Beau M.M., Stoffel W.;
RT   "Human mitochondrial enoyl-CoA hydratase gene (ECHS1): structural
RT   organization and assignment to chromosome 10q26.2-q26.3.";
RL   Genomics 40:470-475(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-75.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT ILE-75.
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PROTEIN SEQUENCE OF 28-37.
RC   TISSUE=Liver;
RX   PubMed=1286669; DOI=10.1002/elps.11501301201;
RA   Hochstrasser D.F., Frutiger S., Paquet N., Bairoch A., Ravier F.,
RA   Pasquali C., Sanchez J.-C., Tissot J.-D., Bjellqvist B., Vargas R.,
RA   Appel R.D., Hughes G.J.;
RT   "Human liver protein map: a reference database established by
RT   microsequencing and gel comparison.";
RL   Electrophoresis 13:992-1001(1992).
RN   [7]
RP   PROTEIN SEQUENCE OF 44-56; 102-115; 158-178; 186-197; 242-257 AND
RP   262-273, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Vishwanath V., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   PROTEIN SEQUENCE OF 57-63; 75-92 AND 158-178, VARIANT ILE-75, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Liver;
RX   PubMed=11271497;
RX   DOI=10.1002/1522-2683(200011)21:17<3785::AID-ELPS3785>3.0.CO;2-2;
RA   Hubbard M.J., McHugh N.J.;
RT   "Human ERp29: isolation, primary structural characterisation and two-
RT   dimensional gel mapping.";
RL   Electrophoresis 21:3785-3796(2000).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-118, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   INVOLVEMENT IN ECHS1D, AND VARIANT ECHS1D ASP-158.
RX   PubMed=25125611; DOI=10.1093/brain/awu216;
RA   Peters H., Buck N., Wanders R., Ruiter J., Waterham H., Koster J.,
RA   Yaplito-Lee J., Ferdinandusse S., Pitt J.;
RT   "ECHS1 mutations in Leigh disease: a new inborn error of metabolism
RT   affecting valine metabolism.";
RL   Brain 137:2903-2908(2014).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-46 AND SER-114, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   INVOLVEMENT IN ECHS1D, AND VARIANT ECHS1D VAL-2.
RX   PubMed=25393721; DOI=10.1002/humu.22730;
RA   Sakai C., Yamaguchi S., Sasaki M., Miyamoto Y., Matsushima Y.,
RA   Goto Y.;
RT   "ECHS1 mutations cause combined respiratory chain deficiency resulting
RT   in Leigh syndrome.";
RL   Hum. Mutat. 36:232-239(2015).
RN   [14]
RP   CLEAVAGE OF TRANSIT PEPTIDE [LARGE SCALE ANALYSIS] AFTER PHE-27, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   X-RAY CRYSTALLOGRAPHY (2.55 ANGSTROMS) OF 24-290 IN COMPLEX WITH
RP   CROTONYL COENZYME A, AND SUBUNIT.
RG   Structural genomics consortium (SGC);
RT   "The crystal structure of human enoyl-coenzyme A (CoA) hydratase short
RT   chain 1, ECHS1.";
RL   Submitted (AUG-2006) to the PDB data bank.
RN   [16]
RP   VARIANTS ECHS1D SER-33; HIS-54; SER-59; THR-66; GLN-77; ARG-90;
RP   THR-132; GLY-150; ARG-159; SER-195; ARG-225 AND GLU-273.
RX   PubMed=26000322; DOI=10.1002/acn3.189;
RA   Haack T.B., Jackson C.B., Murayama K., Kremer L.S., Schaller A.,
RA   Kotzaeridou U., de Vries M.C., Schottmann G., Santra S., Buechner B.,
RA   Wieland T., Graf E., Freisinger P., Eggimann S., Ohtake A.,
RA   Okazaki Y., Kohda M., Kishita Y., Tokuzawa Y., Sauer S., Memari Y.,
RA   Kolb-Kokocinski A., Durbin R., Hasselmann O., Cremer K., Albrecht B.,
RA   Wieczorek D., Engels H., Hahn D., Zink A.M., Alston C.L., Taylor R.W.,
RA   Rodenburg R.J., Trollmann R., Sperl W., Strom T.M., Hoffmann G.F.,
RA   Mayr J.A., Meitinger T., Bolognini R., Schuelke M., Nuoffer J.M.,
RA   Koelker S., Prokisch H., Klopstock T.;
RT   "Deficiency of ECHS1 causes mitochondrial encephalopathy with cardiac
RT   involvement.";
RL   Ann. Clin. Transl. Neurol. 2:492-509(2015).
RN   [17]
RP   VARIANTS ECHS1D SER-59 AND VAL-138, FUNCTION, BIOPHYSICOCHEMICAL
RP   PROPERTIES, CATALYTIC ACTIVITY, AND PATHWAY.
RX   PubMed=26251176; DOI=10.1136/jmedgenet-2015-103231;
RA   Yamada K., Aiba K., Kitaura Y., Kondo Y., Nomura N., Nakamura Y.,
RA   Fukushi D., Murayama K., Shimomura Y., Pitt J., Yamaguchi S.,
RA   Yokochi K., Wakamatsu N.;
RT   "Clinical, biochemical and metabolic characterisation of a mild form
RT   of human short-chain enoyl-CoA hydratase deficiency: significance of
RT   increased N-acetyl-S-(2-carboxypropyl)cysteine excretion.";
RL   J. Med. Genet. 52:691-698(2015).
RN   [18]
RP   VARIANT ECHS1D GLY-281.
RX   PubMed=27221955; DOI=10.1007/s11011-016-9842-x;
RA   Nair P., Hamzeh A.R., Mohamed M., Malik E.M., Al-Ali M.T., Bastaki F.;
RT   "Novel ECHS1 mutation in an Emirati neonate with severe metabolic
RT   acidosis.";
RL   Metab. Brain Dis. 31:1189-1192(2016).
RN   [19]
RP   VARIANTS ECHS1D SER-33; SER-59 AND ARG-159.
RX   PubMed=26741492; DOI=10.1371/journal.pgen.1005679;
RA   Kohda M., Tokuzawa Y., Kishita Y., Nyuzuki H., Moriyama Y., Mizuno Y.,
RA   Hirata T., Yatsuka Y., Yamashita-Sugahara Y., Nakachi Y., Kato H.,
RA   Okuda A., Tamaru S., Borna N.N., Banshoya K., Aigaki T.,
RA   Sato-Miyata Y., Ohnuma K., Suzuki T., Nagao A., Maehata H.,
RA   Matsuda F., Higasa K., Nagasaki M., Yasuda J., Yamamoto M.,
RA   Fushimi T., Shimura M., Kaiho-Ichimoto K., Harashima H., Yamazaki T.,
RA   Mori M., Murayama K., Ohtake A., Okazaki Y.;
RT   "A comprehensive genomic analysis reveals the genetic landscape of
RT   mitochondrial respiratory chain complex deficiencies.";
RL   PLoS Genet. 12:E1005679-E1005679(2016).
CC   -!- FUNCTION: Straight-chain enoyl-CoA thioesters from C4 up to at
CC       least C16 are processed, although with decreasing catalytic rate.
CC       Has high substrate specificity for crotonyl-CoA and moderate
CC       specificity for acryloyl-CoA, 3-methylcrotonyl-CoA and
CC       methacrylyl-CoA. It is noteworthy that binds tiglyl-CoA, but
CC       hydrates only a small amount of this substrate.
CC       {ECO:0000269|PubMed:26251176}.
CC   -!- CATALYTIC ACTIVITY: (3S)-3-hydroxyacyl-CoA = trans-2(or 3)-enoyl-
CC       CoA + H(2)O. {ECO:0000269|PubMed:26251176}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=12.75 uM for crotonyl-CoA {ECO:0000269|PubMed:26251176};
CC         KM=34.04 uM for acryloyl-CoA {ECO:0000269|PubMed:26251176};
CC         KM=45.83 uM for 3-Methylcrotonyl-CoA
CC         {ECO:0000269|PubMed:26251176};
CC         KM=57.87 uM for tiglyl-CoA {ECO:0000269|PubMed:26251176};
CC         Vmax=54.64 umol/min/mg enzyme toward crotonyl-CoA
CC         {ECO:0000269|PubMed:26251176};
CC         Vmax=42.92 umol/min/mg enzyme toward acryloyl-CoA
CC         {ECO:0000269|PubMed:26251176};
CC         Vmax=49.02 umol/min/mg enzyme toward 3-Methylcrotonyl-CoA
CC         {ECO:0000269|PubMed:26251176};
CC         Vmax=6.66 umol/min/mg enzyme toward tiglyl-CoA
CC         {ECO:0000269|PubMed:26251176};
CC   -!- PATHWAY: Lipid metabolism; fatty acid beta-oxidation.
CC       {ECO:0000269|PubMed:26251176}.
CC   -!- SUBUNIT: Homohexamer; dimer of trimers. {ECO:0000269|Ref.15}.
CC   -!- INTERACTION:
CC       Q5S007:LRRK2; NbExp=2; IntAct=EBI-719602, EBI-5323863;
CC       P40763:STAT3; NbExp=3; IntAct=EBI-719602, EBI-518675;
CC       P42227:Stat3 (xeno); NbExp=3; IntAct=EBI-719602, EBI-602878;
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix.
CC   -!- TISSUE SPECIFICITY: Liver, fibroblast, muscle. Barely detectable
CC       in spleen and kidney.
CC   -!- DISEASE: Mitochondrial short-chain enoyl-CoA hydratase 1
CC       deficiency (ECHS1D) [MIM:616277]: A severe, autosomal recessive
CC       inborn error affecting valine metabolism. Disease features include
CC       brain lesions in the basal ganglia, neurodegeneration, delayed
CC       psychomotor development, hypotonia, spasticity, and increased
CC       lactic acid in serum and cerebral serum fluid.
CC       {ECO:0000269|PubMed:25125611, ECO:0000269|PubMed:25393721,
CC       ECO:0000269|PubMed:26000322, ECO:0000269|PubMed:26251176,
CC       ECO:0000269|PubMed:26741492, ECO:0000269|PubMed:27221955}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the enoyl-CoA hydratase/isomerase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D13900; BAA03001.1; -; mRNA.
DR   EMBL; X98126; CAA66808.1; -; Genomic_DNA.
DR   EMBL; X98127; CAA66808.1; JOINED; Genomic_DNA.
DR   EMBL; X98128; CAA66808.1; JOINED; Genomic_DNA.
DR   EMBL; X98129; CAA66808.1; JOINED; Genomic_DNA.
DR   EMBL; BT007123; AAP35787.1; -; mRNA.
DR   EMBL; AL360181; CAH70286.1; -; Genomic_DNA.
DR   EMBL; BC008906; AAH08906.1; -; mRNA.
DR   CCDS; CCDS7681.1; -.
DR   RefSeq; NP_004083.3; NM_004092.3.
DR   UniGene; Hs.76394; -.
DR   PDB; 2HW5; X-ray; 2.55 A; A/B/C/D/E/F=28-290.
DR   PDBsum; 2HW5; -.
DR   ProteinModelPortal; P30084; -.
DR   SMR; P30084; -.
DR   BioGrid; 108221; 60.
DR   IntAct; P30084; 26.
DR   MINT; MINT-1401929; -.
DR   STRING; 9606.ENSP00000357535; -.
DR   DrugBank; DB03059; Acetoacetyl-Coenzyme A.
DR   DrugBank; DB02563; Hexanoyl-Coenzyme A.
DR   DrugBank; DB02910; Octanoyl-Coenzyme A.
DR   SwissLipids; SLP:000001471; -.
DR   iPTMnet; P30084; -.
DR   PhosphoSitePlus; P30084; -.
DR   SwissPalm; P30084; -.
DR   BioMuta; ECHS1; -.
DR   DMDM; 62906863; -.
DR   DOSAC-COBS-2DPAGE; P30084; -.
DR   REPRODUCTION-2DPAGE; IPI00024993; -.
DR   REPRODUCTION-2DPAGE; P30084; -.
DR   SWISS-2DPAGE; P30084; -.
DR   UCD-2DPAGE; P30084; -.
DR   EPD; P30084; -.
DR   MaxQB; P30084; -.
DR   PaxDb; P30084; -.
DR   PeptideAtlas; P30084; -.
DR   PRIDE; P30084; -.
DR   TopDownProteomics; P30084; -.
DR   DNASU; 1892; -.
DR   Ensembl; ENST00000368547; ENSP00000357535; ENSG00000127884.
DR   GeneID; 1892; -.
DR   KEGG; hsa:1892; -.
DR   UCSC; uc001lmu.4; human.
DR   CTD; 1892; -.
DR   DisGeNET; 1892; -.
DR   GeneCards; ECHS1; -.
DR   HGNC; HGNC:3151; ECHS1.
DR   HPA; CAB003783; -.
DR   HPA; HPA021995; -.
DR   HPA; HPA022476; -.
DR   MalaCards; ECHS1; -.
DR   MIM; 602292; gene.
DR   MIM; 616277; phenotype.
DR   neXtProt; NX_P30084; -.
DR   OpenTargets; ENSG00000127884; -.
DR   PharmGKB; PA27597; -.
DR   eggNOG; KOG1680; Eukaryota.
DR   eggNOG; COG1024; LUCA.
DR   GeneTree; ENSGT00870000136389; -.
DR   HOGENOM; HOG000027939; -.
DR   HOVERGEN; HBG010157; -.
DR   InParanoid; P30084; -.
DR   KO; K07511; -.
DR   OMA; VSKIYPV; -.
DR   OrthoDB; EOG091G0MVQ; -.
DR   PhylomeDB; P30084; -.
DR   TreeFam; TF314497; -.
DR   BioCyc; MetaCyc:HS05132-MONOMER; -.
DR   BRENDA; 4.2.1.17; 2681.
DR   Reactome; R-HSA-77310; Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA.
DR   Reactome; R-HSA-77346; Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA.
DR   Reactome; R-HSA-77348; Beta oxidation of octanoyl-CoA to hexanoyl-CoA.
DR   Reactome; R-HSA-77350; Beta oxidation of hexanoyl-CoA to butanoyl-CoA.
DR   Reactome; R-HSA-77352; Beta oxidation of butanoyl-CoA to acetyl-CoA.
DR   SABIO-RK; P30084; -.
DR   UniPathway; UPA00659; -.
DR   ChiTaRS; ECHS1; human.
DR   EvolutionaryTrace; P30084; -.
DR   GeneWiki; ECHS1; -.
DR   GenomeRNAi; 1892; -.
DR   PRO; PR:P30084; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000127884; -.
DR   CleanEx; HS_ECHS1; -.
DR   Genevisible; P30084; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005759; C:mitochondrial matrix; TAS:Reactome.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0004300; F:enoyl-CoA hydratase activity; IDA:UniProtKB.
DR   GO; GO:0006635; P:fatty acid beta-oxidation; IDA:UniProtKB.
DR   Gene3D; 1.10.12.10; -; 1.
DR   InterPro; IPR029045; ClpP/crotonase-like_dom.
DR   InterPro; IPR014748; Crontonase_C.
DR   InterPro; IPR001753; Crotonase_core_superfam.
DR   InterPro; IPR018376; Enoyl-CoA_hyd/isom_CS.
DR   Pfam; PF00378; ECH_1; 1.
DR   SUPFAM; SSF52096; SSF52096; 1.
DR   PROSITE; PS00166; ENOYL_COA_HYDRATASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Fatty acid metabolism;
KW   Lipid metabolism; Lyase; Mitochondrion; Neurodegeneration;
KW   Phosphoprotein; Polymorphism; Reference proteome; Transit peptide.
FT   TRANSIT       1     27       Mitochondrion.
FT                                {ECO:0000244|PubMed:25944712,
FT                                ECO:0000269|PubMed:1286669}.
FT   CHAIN        28    290       Enoyl-CoA hydratase, mitochondrial.
FT                                /FTId=PRO_0000007411.
FT   REGION       98    101       Substrate binding.
FT   BINDING     141    141       Substrate; via amide nitrogen.
FT   SITE        164    164       Important for catalytic activity.
FT                                {ECO:0000250}.
FT   MOD_RES      46     46       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     101    101       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BH95}.
FT   MOD_RES     101    101       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BH95}.
FT   MOD_RES     114    114       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     115    115       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BH95}.
FT   MOD_RES     115    115       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:Q8BH95}.
FT   MOD_RES     118    118       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     204    204       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BH95}.
FT   MOD_RES     211    211       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q8BH95}.
FT   VARIANT       2      2       A -> V (in ECHS1D; dbSNP:rs587776498).
FT                                {ECO:0000269|PubMed:25393721}.
FT                                /FTId=VAR_073373.
FT   VARIANT      11     11       V -> A (in dbSNP:rs10466126).
FT                                {ECO:0000269|PubMed:8012501,
FT                                ECO:0000269|PubMed:9073515}.
FT                                /FTId=VAR_022273.
FT   VARIANT      33     33       F -> S (in ECHS1D).
FT                                {ECO:0000269|PubMed:26000322,
FT                                ECO:0000269|PubMed:26741492}.
FT                                /FTId=VAR_076185.
FT   VARIANT      54     54       R -> H (in ECHS1D; dbSNP:rs375266808).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076186.
FT   VARIANT      59     59       N -> S (in ECHS1D; decreases
FT                                significantly enoyl-CoA hydratase
FT                                activity; decreases significantly protein
FT                                expression; dbSNP:rs201865375).
FT                                {ECO:0000269|PubMed:26000322,
FT                                ECO:0000269|PubMed:26251176,
FT                                ECO:0000269|PubMed:26741492}.
FT                                /FTId=VAR_076187.
FT   VARIANT      66     66       I -> T (in ECHS1D; dbSNP:rs371063211).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076188.
FT   VARIANT      75     75       T -> I (in dbSNP:rs1049951).
FT                                {ECO:0000269|PubMed:11271497,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8012501,
FT                                ECO:0000269|PubMed:9073515,
FT                                ECO:0000269|Ref.3}.
FT                                /FTId=VAR_022274.
FT   VARIANT      77     77       E -> Q (in ECHS1D).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076189.
FT   VARIANT      90     90       G -> R (in ECHS1D; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076190.
FT   VARIANT     132    132       A -> T (in ECHS1D; dbSNP:rs770931871).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076191.
FT   VARIANT     138    138       A -> V (in ECHS1D; decreases enoyl-CoA
FT                                hydratase activity of 70%; decreases
FT                                significantly protein expression;
FT                                dbSNP:rs864309656).
FT                                {ECO:0000269|PubMed:26251176}.
FT                                /FTId=VAR_076479.
FT   VARIANT     150    150       D -> G (in ECHS1D).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076192.
FT   VARIANT     158    158       A -> D (in ECHS1D; dbSNP:rs786204001).
FT                                {ECO:0000269|PubMed:25125611}.
FT                                /FTId=VAR_073374.
FT   VARIANT     159    159       Q -> R (in ECHS1D; dbSNP:rs375032130).
FT                                {ECO:0000269|PubMed:26000322,
FT                                ECO:0000269|PubMed:26741492}.
FT                                /FTId=VAR_076193.
FT   VARIANT     195    195       G -> S (in ECHS1D; dbSNP:rs761989177).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076194.
FT   VARIANT     225    225       C -> R (in ECHS1D; dbSNP:rs769429279).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076195.
FT   VARIANT     273    273       K -> E (in ECHS1D; dbSNP:rs565090080).
FT                                {ECO:0000269|PubMed:26000322}.
FT                                /FTId=VAR_076196.
FT   VARIANT     281    281       E -> G (in ECHS1D; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:27221955}.
FT                                /FTId=VAR_076480.
FT   CONFLICT     84     84       A -> G (in Ref. 1; BAA03001).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       D -> G (in Ref. 1; BAA03001).
FT                                {ECO:0000305}.
FT   CONFLICT    138    138       A -> P (in Ref. 1; BAA03001).
FT                                {ECO:0000305}.
FT   CONFLICT    188    189       AM -> EL (in Ref. 1; BAA03001).
FT                                {ECO:0000305}.
FT   CONFLICT    197    197       R -> A (in Ref. 1; BAA03001).
FT                                {ECO:0000305}.
FT   STRAND       34     42       {ECO:0000244|PDB:2HW5}.
FT   HELIX        43     45       {ECO:0000244|PDB:2HW5}.
FT   STRAND       47     52       {ECO:0000244|PDB:2HW5}.
FT   HELIX        55     57       {ECO:0000244|PDB:2HW5}.
FT   HELIX        63     78       {ECO:0000244|PDB:2HW5}.
FT   STRAND       84     88       {ECO:0000244|PDB:2HW5}.
FT   STRAND       91     95       {ECO:0000244|PDB:2HW5}.
FT   HELIX       100    103       {ECO:0000244|PDB:2HW5}.
FT   HELIX       108    113       {ECO:0000244|PDB:2HW5}.
FT   TURN        114    117       {ECO:0000244|PDB:2HW5}.
FT   HELIX       119    125       {ECO:0000244|PDB:2HW5}.
FT   STRAND      130    134       {ECO:0000244|PDB:2HW5}.
FT   STRAND      136    139       {ECO:0000244|PDB:2HW5}.
FT   HELIX       141    147       {ECO:0000244|PDB:2HW5}.
FT   STRAND      149    155       {ECO:0000244|PDB:2HW5}.
FT   STRAND      159    161       {ECO:0000244|PDB:2HW5}.
FT   HELIX       163    167       {ECO:0000244|PDB:2HW5}.
FT   STRAND      172    174       {ECO:0000244|PDB:2HW5}.
FT   TURN        175    177       {ECO:0000244|PDB:2HW5}.
FT   HELIX       178    183       {ECO:0000244|PDB:2HW5}.
FT   HELIX       185    194       {ECO:0000244|PDB:2HW5}.
FT   HELIX       200    205       {ECO:0000244|PDB:2HW5}.
FT   STRAND      210    213       {ECO:0000244|PDB:2HW5}.
FT   TURN        215    217       {ECO:0000244|PDB:2HW5}.
FT   HELIX       218    231       {ECO:0000244|PDB:2HW5}.
FT   HELIX       234    245       {ECO:0000244|PDB:2HW5}.
FT   HELIX       246    248       {ECO:0000244|PDB:2HW5}.
FT   HELIX       252    266       {ECO:0000244|PDB:2HW5}.
FT   HELIX       270    280       {ECO:0000244|PDB:2HW5}.
SQ   SEQUENCE   290 AA;  31387 MW;  0CCD0C7F891B1704 CRC64;
     MAALRVLLSC VRGPLRPPVR CPAWRPFASG ANFEYIIAEK RGKNNTVGLI QLNRPKALNA
     LCDGLIDELN QALKTFEEDP AVGAIVLTGG DKAFAAGADI KEMQNLSFQD CYSSKFLKHW
     DHLTQVKKPV IAAVNGYAFG GGCELAMMCD IIYAGEKAQF AQPEILIGTI PGAGGTQRLT
     RAVGKSLAME MVLTGDRISA QDAKQAGLVS KICPVETLVE EAIQCAEKIA SNSKIVVAMA
     KESVNAAFEM TLTEGSKLEK KLFYSTFATD DRKEGMTAFV EKRKANFKDQ
//
